Press Announcements
Note: Press announcements from 2004 to 2014 are available through the FDA.gov Archive. Some links in press announcements may no longer be active. For more information, contact FDA’s Office of Media Affairs at 301-796-4540.
June 2017
- June 22, 2017 - FDA approves first subcutaneous C1 Esterase Inhibitor to treat rare genetic disease
- June 20, 2017 - U.S. Marshals seize adulterated food from a Minnesota warehouse
- June 15, 2017 - Statement from FDA Commissioner Scott Gottlieb, M.D., on the 2016 National Youth Tobacco Survey results
- June 15, 2017 - Sonar Products ordered to cease operations, Stratus Pharmaceuticals ordered to cease distributing unapproved drugs
- June 13, 2017 - Statement from FDA Commissioner Scott Gottlieb, M.D. – FDA is taking new steps to help assess opioid drugs with abuse-deterrent properties
- June 08, 2017 - FDA requests removal of Opana ER for risks related to abuse
- June 05, 2017 - FDA expands use of Sapien 3 artificial heart valve for high-risk patients
May 2017
- May 30, 2017 - FDA approves first generic Strattera for the treatment of ADHD
- May 23, 2017 - FDA approves first cancer treatment for any solid tumor with a specific genetic feature
- May 22, 2017 - FDA approves first drug to specifically treat giant cell arteritis
- May 17, 2017 - FDA expands approved use of Kalydeco to treat additional mutations of cystic fibrosis
- May 17, 2017 - FDA warns Americans about risk of inaccurate results from certain lead tests
- May 12, 2017 - FDA authorizes use of new device to treat esophageal birth defect in babies
- May 05, 2017 - FDA approves drug to treat ALS
- May 05, 2017 - FDA takes action against Florida medicated animal feed manufacturer
April 2017
- April 28, 2017 - FDA approves new combination treatment for acute myeloid leukemia
- April 27, 2017 - FDA approves first treatment for a form of Batten disease
- April 27, 2017 - FDA expands approved use of Stivarga to treat liver cancer
- April 25, 2017 - FDA takes action against 14 companies for selling illegal cancer treatments
- April 20, 2017 - FDA statement from Douglas Throckmorton, M.D., deputy center director for regulatory programs, Center for Drug Evaluation and Research, on new warnings about the use of codeine and tramadol in children & nursing mothers
- April 12, 2017 - FDA allows marketing of first whole slide imaging system for digital pathology
- April 11, 2017 - FDA approves first drug to treat tardive dyskinesia
- April 07, 2017 - FDA approves two hepatitis C drugs for pediatric patients
- April 06, 2017 - FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions
March 2017
- March 31, 2017 - FDA alerts consumers of nationwide voluntary recall of EpiPen and EpiPen Jr
- March 29, 2017 - FDA approves new drug to treat multiple sclerosis
- March 28, 2017 - FDA approves new eczema drug Dupixent
- March 27, 2017 - FDA approves maintenance treatment for recurrent epithelial ovarian, fallopian tube or primary peritoneal cancers
- March 23, 2017 - FDA approves first treatment for rare form of skin cancer
- March 21, 2017 - FDA approves drug to treat Parkinson’s disease
- March 14, 2017 - Colorado unapproved drug and dietary supplement makers ordered to cease operations for federal violations
- March 03, 2017 - FDA approves first treatment for frequent urination at night due to overproduction of urine
- March 02, 2017 - Mutual Recognition promises new framework for pharmaceutical inspections for United States and European Union
- March 01, 2017 - FDA approves Odactra for house dust mite allergies
February 2017
- February 28, 2017 - FDA approves Xermelo for carcinoid syndrome diarrhea
- February 23, 2017 - FDA clears test to help manage antibiotic treatment for lower respiratory tract infections and sepsis
- February 23, 2017 - FDA allows marketing of test to identify organisms that cause bloodstream infections and provide antibiotic sensitivity results
- February 21, 2017 - Louisiana drug and dietary supplement maker ordered to cease operations due to federal violations
- February 15, 2017 - FDA approves new psoriasis drug
- February 09, 2017 - FDA approves drug to treat Duchenne muscular dystrophy
- February 09, 2017 - Federal judge approves consent decree with California dietary supplement distributor, Regeneca Worldwide
- February 03, 2017 - FDA permits marketing of first newborn screening system for detection of four, rare metabolic disorders
January 2017
- January 27, 2017 - FDA confirms elevated levels of belladonna in certain homeopathic teething products
- January 19, 2017 - FDA approves Trulance for Chronic Idiopathic Constipation
- January 19, 2017 - Statement from FDA Commissioner Robert Califf, M.D. announcing FDA Oncology Center of Excellence launch
- January 18, 2017 - Statement from FDA Commissioner Robert Califf, M.D. announcing new draft guidances on medical product communications
- January 18, 2017 - FDA and EPA issue final fish consumption advice
- Previous
- 1